{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:55:29Z","timestamp":1790229329043,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T00:00:00Z","timestamp":1407369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10585-014-9672-3","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T15:41:25Z","timestamp":1407339685000},"page":"817-827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm"],"prefix":"10.1007","volume":"31","author":[{"given":"D.","family":"Kaemmerer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Posorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"von Eggeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"H\u00f6rsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kl\u00f6ppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kn\u00f6sel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hommann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,7]]},"reference":[{"issue":"12","key":"9672_CR1","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.6004\/jnccn.2011.0117","volume":"9","author":"DS Ettinger","year":"2011","unstructured":"Ettinger DS, Agulnik M, Cates JM et al (2011) Occult primary. J Natl Compr Cancer Netw 9(12):1358\u20131395","journal-title":"J Natl Compr Cancer Netw"},{"issue":"Suppl 7","key":"9672_CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/annonc\/mdq278","volume":"21","author":"N Pavlidis","year":"2010","unstructured":"Pavlidis N, Pentheroudakis G (2010) Cancer of unknown primary site: 20 questions to be answered. Ann Oncol 21(Suppl 7):303\u2013307","journal-title":"Ann Oncol"},{"issue":"2","key":"9672_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/j.seminoncol.2010.03.009","volume":"37","author":"GJ Morris","year":"2010","unstructured":"Morris GJ, Greco FA, Hainsworth JD et al (2010) Cancer of unknown primary site. Semin Oncol 37(2):71\u201379","journal-title":"Semin Oncol"},{"issue":"6","key":"9672_CR4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/lary.22424","volume":"122","author":"AE Balaker","year":"2012","unstructured":"Balaker AE, Abemayor E, Elashoff D et al (2012) Cancer of unknown primary: does treatment modality make a difference? Laryngoscope 122(6):1279\u20131282","journal-title":"Laryngoscope"},{"issue":"5","key":"9672_CR5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ctrv.2011.03.002","volume":"37","author":"A Stoyianni","year":"2011","unstructured":"Stoyianni A, Pentheroudakis G, Pavlidis N (2011) Neuroendocrine carcinoma of unknown primary: a systematic review of the literature and a comparative study with other neuroendocrine tumors. Cancer Treat Rev 37(5):358\u2013365","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"9672_CR6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00259-009-1205-y","volume":"37","author":"V Prasad","year":"2010","unstructured":"Prasad V, Ambrosini V, Hommann M et al (2010) Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68) Ga-DOTA-NOC receptor PET\/CT. Eur J Nucl Med Mol Imaging 37(1):67\u201377","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"9672_CR7","doi-asserted-by":"crossref","first-page":"e3767","DOI":"10.1371\/journal.pone.0003767","volume":"3","author":"C Melle","year":"2008","unstructured":"Melle C, Ernst G, Schimmel B et al (2008) Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11. PLoS ONE 3(12):e3767","journal-title":"PLoS ONE"},{"issue":"4","key":"9672_CR8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0002-9440(10)62509-6","volume":"159","author":"TJ Giordano","year":"2001","unstructured":"Giordano TJ, Shedden KA, Schwartz DR et al (2001) Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 159(4):1231\u20131238","journal-title":"Am J Pathol"},{"issue":"27","key":"9672_CR9","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1200\/JCO.2007.14.6969","volume":"26","author":"HM Horlings","year":"2008","unstructured":"Horlings HM, van Laar RK, Kerst JM et al (2008) Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary. J Clin Oncol 26(27):4435\u20134441","journal-title":"J Clin Oncol"},{"issue":"2","key":"9672_CR10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1677\/erc.1.01153","volume":"13","author":"G Capurso","year":"2006","unstructured":"Capurso G, Lattimore S, Crnogorac-Jurcevic T et al (2006) Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets. Endocr Relat Cancer 13(2):541\u2013558","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"9672_CR11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10585-011-9397-5","volume":"28","author":"N Posorski","year":"2011","unstructured":"Posorski N, Kaemmerer D, Ernst G et al (2011) Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases. Clin Exp Metastasis 28(7):637\u2013647","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"9672_CR12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1200\/JCO.2012.43.3755","volume":"31","author":"JD Hainsworth","year":"2013","unstructured":"Hainsworth JD, Rubin MS, Spigel DR et al (2013) Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute. J Clin Oncol 31(2):217\u2013223","journal-title":"J Clin Oncol"},{"issue":"7","key":"9672_CR13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1074\/mcp.M300033-MCP200","volume":"2","author":"C Melle","year":"2003","unstructured":"Melle C, Ernst G, Schimmel B et al (2003) Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry. Mol Cell Proteomics 2(7):443\u2013452","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"9672_CR14","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1158\/0008-5472.CAN-03-3807","volume":"64","author":"C Melle","year":"2004","unstructured":"Melle C, Ernst G, Schimmel B et al (2004) A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res 64(12):4099\u20134104","journal-title":"Cancer Res"},{"issue":"3","key":"9672_CR15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00432-011-1107-9","volume":"138","author":"T Knosel","year":"2012","unstructured":"Knosel T, Chen Y, Altendorf-Hofmann A et al (2012) High KIT and PDGFRA are associated with shorter patients survival in gastroenteropancreatic neuroendocrine tumors, but mutations are a rare event. J Cancer Res Clin Oncol 138(3):397\u2013403","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"9672_CR16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1198\/106186006X133933","volume":"15","author":"Torsten Hothorn KHaAZ","year":"2006","unstructured":"Torsten Hothorn KHaAZ (2006) Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat 15(3):651\u2013674","journal-title":"J Comput Graph Stat"},{"key":"9672_CR17","unstructured":"R Development Core Team (2010) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing"},{"issue":"8","key":"9672_CR18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s00259-012-2146-4","volume":"39","author":"V Ambrosini","year":"2012","unstructured":"Ambrosini V, Campana D, Nanni C et al (2012) Is (6) (8)Ga-DOTA-NOC PET\/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour? Eur J Nucl Med Mol Imaging 39(8):1278\u20131283","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9672_CR19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-540-31203-1_18","volume":"170","author":"RP Baum","year":"2008","unstructured":"Baum RP, Prasad V, Hommann M et al (2008) Receptor PET\/CT imaging of neuroendocrine tumors. Recent Results Cancer Res 170:225\u2013242","journal-title":"Recent Results Cancer Res"},{"issue":"3","key":"9672_CR20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.semnuclmed.2012.01.002","volume":"42","author":"RP Baum","year":"2012","unstructured":"Baum RP, Kulkarni HR, Carreras C (2012) Peptides and receptors in image-guided therapy: theranostics for neuroendocrine neoplasms. Semin Nucl Med 42(3):190\u2013207","journal-title":"Semin Nucl Med"},{"issue":"5","key":"9672_CR21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00006231-200405000-00004","volume":"25","author":"G Savelli","year":"2004","unstructured":"Savelli G, Lucignani G, Seregni E et al (2004) Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours. Nucl Med Commun 25(5):445\u2013449","journal-title":"Nucl Med Commun"},{"issue":"3","key":"9672_CR22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/s-0032-1327962","volume":"139","author":"N Begum","year":"2013","unstructured":"Begum N, Hubold C, Buchmann I et al (2013) Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary\u2013a plea for open exploration. Zentralbl Chir 139(3):284\u2013291","journal-title":"Zentralbl Chir"},{"issue":"8","key":"9672_CR23","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/sj.bjc.6604315","volume":"98","author":"J Bridgewater","year":"2008","unstructured":"Bridgewater J, van Laar R, Floore A et al (2008) Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. Br J Cancer 98(8):1425\u20131430","journal-title":"Br J Cancer"},{"issue":"8","key":"9672_CR24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.1790","volume":"14","author":"K Shedden","year":"2008","unstructured":"Shedden K, Taylor JM, Enkemann SA et al (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14(8):822\u2013827","journal-title":"Nat Med"},{"issue":"26","key":"9672_CR25","doi-asserted-by":"crossref","first-page":"15149","DOI":"10.1073\/pnas.211566398","volume":"98","author":"S Ramaswamy","year":"2001","unstructured":"Ramaswamy S, Tamayo P, Rifkin R et al (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98(26):15149\u201315154","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9672_CR26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.889","volume":"195","author":"AA Alizadeh","year":"2001","unstructured":"Alizadeh AA, Ross DT, Perou CM et al (2001) Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195(1):41\u201352","journal-title":"J Pathol"},{"issue":"20","key":"9672_CR27","first-page":"7388","volume":"61","author":"AI Su","year":"2001","unstructured":"Su AI, Welsh JB, Sapinoso LM et al (2001) Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61(20):7388\u20137393","journal-title":"Cancer Res"},{"issue":"1","key":"9672_CR28","doi-asserted-by":"crossref","first-page":"e53406","DOI":"10.1371\/journal.pone.0053406","volume":"8","author":"V Musella","year":"2013","unstructured":"Musella V, Verderio P, Reid JF et al (2013) Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa. PLoS ONE 8(1):e53406","journal-title":"PLoS ONE"},{"issue":"1","key":"9672_CR29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/path.893","volume":"195","author":"L Bubendorf","year":"2001","unstructured":"Bubendorf L, Nocito A, Moch H et al (2001) Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 195(1):72\u201379","journal-title":"J Pathol"},{"issue":"5","key":"9672_CR30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/PAS.0b013e31824aba59","volume":"36","author":"ES Chan","year":"2012","unstructured":"Chan ES, Alexander J, Swanson PE et al (2012) PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms. Am J Surg Pathol 36(5):737\u2013743","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"9672_CR31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/modpathol.2013.40","volume":"26","author":"A Agaimy","year":"2013","unstructured":"Agaimy A, Erlenbach-Wunsch K, Konukiewitz B et al (2013) ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin. Mod Pathol 26(7):995\u20131003","journal-title":"Mod Pathol"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-014-9672-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-014-9672-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-014-9672-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T23:47:30Z","timestamp":1598140050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-014-9672-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["9672"],"URL":"https:\/\/doi.org\/10.1007\/s10585-014-9672-3","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,7]]}}}